Androgen suppresses proliferation of castration-resistant LNCaP 104-R2 prostate cancer cells through androgen receptor, Skp2, and c-Myc. [electronic resource]
Producer: 20111219Description: 2022-8 p. digitalISSN:- 1349-7006
- Adenocarcinoma -- metabolism
- Androgen Antagonists -- pharmacology
- Anilides -- pharmacology
- Animals
- Cell Cycle -- drug effects
- Cell Division
- Cell Line, Tumor -- drug effects
- Cyclin-Dependent Kinase Inhibitor p27 -- biosynthesis
- Drug Implants
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Lymphatic Metastasis
- Male
- Metribolone -- pharmacology
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Neoplasm Proteins -- biosynthesis
- Nitriles -- pharmacology
- Orchiectomy
- Prostatic Neoplasms -- metabolism
- Proto-Oncogene Proteins c-myc -- biosynthesis
- Receptors, Androgen
- S-Phase Kinase-Associated Proteins -- biosynthesis
- Testosterone -- administration & dosage
- Tosyl Compounds -- pharmacology
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.